| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Sachs Bruce I51 | Director | Sale+OE | 21,300 | $326.73 | $6,959,421.75 | -12.4% | +4.7% | +22.6% | |
| Apr 4, 2023 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 522 | $315.81 | $164,854.34 | -0.2% | +10.5% | +30.0% | |
| Mar 24, 2023 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 1,768 | $305.38 | $539,911.84 | -3.4% | +10.7% | +32.2% | |
| Mar 17, 2023 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 2,000 | $296.39 | $592,786.00 | -0.6% | +18.0% | +37.8% | |
| Mar 16, 2023 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 2,746 | $300.59 | $825,422.76 | -2.7% | +13.4% | +35.6% | |
| Mar 13, 2023 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 4,754 | $291.98 | $1,388,054.29 | -0.6% | +16.1% | +40.5% | |
| Feb 27, 2023 | Arbuckle Stuart A | EVP, COO | Sell | 5,034 | $287.47 | $1,447,143.44 | -2.8% | +13.2% | +49.9% | |
| Feb 27, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 4,238 | $287.51 | $1,218,449.48 | -4.2% | +13.2% | +49.9% | |
| Feb 27, 2023 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 354 | $287.48 | $101,768.23 | -0.2% | +13.2% | +49.9% | |
| Feb 27, 2023 | Ambrose Kristen | SVP &Chief Accounting Officer | Sell | 1,207 | $287.55 | $347,072.40 | -5.2% | +13.2% | +49.9% |